2015
DOI: 10.1038/am.2015.67
|View full text |Cite
|
Sign up to set email alerts
|

Gd(III) ion-chelated supramolecular assemblies composed of PGMA-based polycations for effective biomedical applications

Abstract: Ethanolamine (EA) or ethylenediamine (ED)-functionalized poly(glycidyl methacrylate) (PGMA), namely PGEA or PGED, has recently been used as effective gene carriers because of their low cytotoxicity and high transfection efficiency. In this study, a series of PGMA-based supramolecular polycations (PGED-Gd@PGEAs) with magnetic resonance imaging (MRI) functions were readily constructed by assembling multiple adamantine-headed star PGEA (Ad-PGEA) units with a versatile PGED-CD-Gd backbone, which possessed numerous… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(34 citation statements)
references
References 45 publications
0
34
0
Order By: Relevance
“…3 Recently, ribozymes, deoxyribozymes (DNAzymes), antisense oligonucleotides and short interfering RNAs have been actively investigated due to their potential application in gene inactivation or downregulation. [4][5][6] Among these therapeutic agents, DNAzymes, which can be engineered to bind to complementary sequences in a target messenger RNA (mRNA) and then cleave it at predetermined phosphodiester linkages, are particularly attractive due to their easy, low-cost synthesis, high selectivity and significant catalytic efficiency. [7][8][9] Despite the increasing interest in DNAzyme-mediated gene silencing as a therapeutic strategy, safety and efficiency remain the critical hurdles to overcome for practical applications.…”
Section: Introductionmentioning
confidence: 99%
“…3 Recently, ribozymes, deoxyribozymes (DNAzymes), antisense oligonucleotides and short interfering RNAs have been actively investigated due to their potential application in gene inactivation or downregulation. [4][5][6] Among these therapeutic agents, DNAzymes, which can be engineered to bind to complementary sequences in a target messenger RNA (mRNA) and then cleave it at predetermined phosphodiester linkages, are particularly attractive due to their easy, low-cost synthesis, high selectivity and significant catalytic efficiency. [7][8][9] Despite the increasing interest in DNAzyme-mediated gene silencing as a therapeutic strategy, safety and efficiency remain the critical hurdles to overcome for practical applications.…”
Section: Introductionmentioning
confidence: 99%
“…The plasmid DNA (pDNA) condensation ability of the prepared PRPs at different weight ratios (w/w) was analyzed by agarose gel electrophoresis as described in our earlier work . Figure a shows that PRP1 is able to condense pDNA well at the weight ratio of 2.5, while PRP2 and PRP3 exhibit similar condensation abilities at the weight ratio of 1.5.…”
Section: Resultsmentioning
confidence: 99%
“…The transfection performance of PRP was first analyzed with the reporter gene pDNA including encoding Renilla luciferase (pRL‐CMV) in the selected HEK293, HepG2 and 4T1 cell lines at various mass ratios, where the branched PEI (25 kDa) at its optimal N/P ratio of 10 was taken as the control . As shown in Figure b, the optimal transfection efficiencies were observed at the weight ratio of 40.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…[35][36][37][38][39] PEGMA was incorporated into the system to enhance the water solubility and to improve the stability of the polyplexes under serum conditions. PGEA has been widely explored as an alternative cationic segment for gene delivery with a better cell viability profile compared with poly(di-methyl-aminoethylmethacrylate) (PDMAEMA) and polyethyleneimine (PEI).…”
Section: Introductionmentioning
confidence: 99%